Dr. Peter Schellongowski is an Assoc. Prof. of Medicine and senior intensivist at the Department of Medicine I at the Medical University of Vienna, Austria. His clinical and scientific focus are different aspects of critically ill cancer and other immunosuppressed patients, as well as ARDS management including various modes of ECLS. He is co-founder of the Austrian-German initiative ‘Intensive Care in Hematologic and Oncologic Patients (iCHOP)’, former co-chair of NEXT (ESICM), coordinator of the ‘iCHOP Registry for Critically Ill Cancer Patients’, the ESICM endorsed YELENNA study (Nine-i) and co-investigator of the UK-led DeVENT study (EU Horizon 2020 FTI grant). He currently serves on the Euro ELSO Scientific Committee, where he coordinates the newly established webinar program, as well as on the Scientific Overview Committee of ELSO.